- About Breast Cancer
- Community Impact
- Get Involved
2020 Networking & Komen Scholar Dinner
Dr. Ben Ho-Park
Enjoy an evening of networking, dinner and an education program presented by Drs. Blackwood & Toppmeyer featuring Komen Scholar Dr. Ben Ho Park.
Seats are limited — register for FREE today!
Monday, February 10 • 5:30 pm – 7 pm
Rutgers Cancer Institute of New Jersey
195 Little Albany St.
New Brunswick, NJ 08901
5:30 PM — Registration & Networking
6 PM — Dinner & Program
6:45 PM — Q&A with hosts & Komen Scholar
Dr. Ben Ho-Park
Komen Scholar Since 2017
Vanderbilt-Ingram Cancer Center
Ben Ho Park, M.D., Ph.D., is the Donna Hall Professor of Medicine at Vanderbilt University Medical Center. He is also Co-Leader of the Breast Cancer Research Program, Associate Director for Translational Research and Director of Precision Oncology for Vanderbilt-Ingram Cancer Center. He received his M.D. and Ph.D. degrees in 1995 at The University of Pennsylvania School of Medicine. Further specializing in Internal Medicine and Hematology/Oncology, he went to Johns Hopkins for a postdoctoral fellowship in cancer genetics, before joining its faculty in 2002. Dr. Park’s research focuses on using genetic models to identify, validate and develop targeted therapies for breast cancer. He specifically studies the PI3 Kinase/AKT signaling pathway and his work identified high frequency of mutation in the PIK3CA gene in human breast cancers, opening the door for PI3K-targeted therapies in breast cancer.
With Komen-funding, Dr. Park is pursuing his efforts in precision oncology: specific drugs to specific patients, focusing on targeting mutations in a gene called SF3B1 that are present only in cancer cells and not normal cells.